Format

Send to

Choose Destination
Neuromuscul Disord. 2018 Jan;28(1):64-76. doi: 10.1016/j.nmd.2017.05.012. Epub 2017 May 15.

Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop: Morbidity due to osteoporosis in DMD: The Path Forward May 12-13, 2016, Bethesda, Maryland, USA.

Author information

1
Division of Endocrinology and Metabolism, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada. Electronic address: Lward@cheo.on.ca.
2
Parent Project Muscular Dystrophy, Middletown, OH, USA.
3
Indiana Center for Musculoskeletal Health, Departments of Anatomy and Cell Biology and Orthopaedic Surgery, Indiana University, Indianapolis, IN, USA.
4
St Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada.
5
Stanford University, Stanford, California, USA.
6
Indiana University School of Medicine, Indiana, USA.
7
University of Texas, Arlington, Texas, USA.
8
Co-Chair, University Missouri, Kansas City, Missouri, USA.
9
Catabasis Pharmaceuticals, Cambridge, Massachusetts, USA.
10
Reveragen, Rockville, Maryland, USA.
11
Parent Project Muscular Dystrophy, Middletown, Ohio, USA.
12
Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
13
Gillette Children's Specialty Healthcare, St. Paul, Minnesota, USA.
14
Ohio State University, Columbus, Ohio, USA.
15
Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada.
16
Co-Chair, Children's Hospital of Eastern Ontario, University of Ottawa, Ontario, Canada.
17
Indiana University, Indianapolis, Indiana, USA.
PMID:
28756052
DOI:
10.1016/j.nmd.2017.05.012

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center